ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.

Anne F Luetkemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.